Publications by authors named "J L Seltzer"
"When you can measure what you are speaking about, and express it in numbers, you know something about it." is a famous quote attributed to Lord Kelvin. This sentiment puts viral load measurements at the center of virology.
View Article and Find Full Text PDFArticle Synopsis
- Rattlesnake envenomations are common in the U.S., with two main antivenoms available: CroFab® and ANAVIP®.
- A study reviewed 481 cases of rattlesnake bites treated with these antivenoms between 2018 and 2022, focusing on adverse effects.
- Results show that CroFab® had a higher rate of severe adverse events (1.5%) compared to ANAVIP®, which had none, indicating that both antivenoms are generally safe but ANAVIP® may have a better safety profile.
Article Synopsis
- Tranexamic acid is often used to stop bleeding in various medical fields, but its potential toxicity, especially when administered through nebulization or BAL, hasn't been fully explored.
- A case was reported where a 44-year-old man experienced serious side effects after receiving the drug during a bronchoscopy, including changes in mental status and muscle spasms.
- As the drug's use in lung treatments grows, healthcare providers should be cautious about its toxicity and consider lower doses or alternative treatments for older patients or those with specific health conditions.
Racial and ethnic disparities in treatment refusal for head and neck cutaneous malignancies.
J Plast Reconstr Aesthet Surg
December 2024
Article Synopsis
- Racial and ethnic minorities, particularly Black and Hispanic patients, show worse outcomes in skin cancer treatment compared to non-Hispanic White patients, with Black patients having the highest rates of treatment refusal.* -
- An analysis of over 151,000 patients revealed that Black and Hispanic individuals faced longer delays from diagnosis to treatment and greater tumor depth, contributing to a higher 90-day mortality rate.* -
- The findings highlight a pressing need for further research on quality of life and targeted interventions to address these disparities in skin cancer outcomes.*